PT - JOURNAL ARTICLE AU - Le Treut, Guillaume AU - Huber, Greg AU - Kamb, Mason AU - Kawagoe, Kyle AU - McGeever, Aaron AU - Miller, Jonathan AU - Pnini, Reuven AU - Veytsman, Boris AU - Yllanes, David TI - A high-resolution flux-matrix model describes the spread of diseases in a spatial network and the effect of mitigation strategies AID - 10.1101/2021.12.22.21268059 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.22.21268059 4099 - http://medrxiv.org/content/early/2022/08/22/2021.12.22.21268059.short 4100 - http://medrxiv.org/content/early/2022/08/22/2021.12.22.21268059.full AB - Propagation of an epidemic across a spatial network of communities is described by a variant of the SIR model accompanied by an intercommunity infectivity matrix. This matrix is estimated from fluxes between communities, obtained from cell-phone tracking data recorded in the USA between March 2020 and February 2021. We apply this model to the SARS-CoV-2 pandemic by fitting just one global parameter representing the frequency of interaction between individuals. We find that the predicted infections agree reasonably well with the reported cases. We clearly see the effect of “shelter-in-place” policies introduced at the onset of the pandemic. Interestingly, a model with uniform transmission rates produces similar results, suggesting that the epidemic transmission was deeply influenced by air travel. We then study the effect of alternative mitigation policies, in particular restricting long-range travel. We find that this policy is successful in decreasing the epidemic size and slowing down the spread, but less effective than the shelter-in-place policy. This policy can result in a pulled wave of infections. We express its velocity and characterize the shape of the traveling front as a function of the epidemiological parameters. Finally, we discuss a policy of selectively constraining travel based on an edge-betweenness criterion.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors acknowledge the generous support of the Chan Zuckerberg Initiative and Chan Zuckerberg Biohub. The authors also thank Mark Rychnovsky for useful conversations on random matrix theory in the early stages of this project, and Naomi Rankin for her help with a preliminary version of the lattice simulations. D.Y. acknowledges support by MINECO (Spain) through Grant No. PGC2018-094684-B-C21, partially funded by the European Regional Development Fund (FEDER).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/czbiohub/epidemiology_flux_model and upon reasonable request to the authors. https://github.com/czbiohub/epidemiology_flux_model